MISGAV, Israel, April 20, 2015 /PRNewswire/ --Endobetix Ltd., a developer of a minimally invasive, nonsurgical implant for the treatment of type 2 diabetes and obesity and a portfolio company of The Trendlines Group, announced today it has been selected as a finalist for Red Herring's Top 100 Europe award, a prestigious list honoring the year's most promising private technology ventures from the European business region.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
